Editorial: Exploration of genetic variation, drug response, and interactions between gastrointestinal disorders and other diseases.
作者信息
Tong Shuangshuang, Lyu Yanlin, Luo Ruibang, Leung Felix, Sha Weihong, Chen Hao
机构信息
Department of Gastroenterology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
出版信息
Front Pharmacol. 2023 Sep 13;14:1287441. doi: 10.3389/fphar.2023.1287441. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Exploration of genetic variation, drug response, and interactions between gastrointestinal disorders and other diseases.
Front Pharmacol. 2023 Sep 13;14:1287441. doi: 10.3389/fphar.2023.1287441. eCollection 2023.
2
Genetic testing in other GI diseases.
Best Pract Res Clin Gastroenterol. 2009;23(2):245-56. doi: 10.1016/j.bpg.2009.02.008.
3
Synergism interaction between genetic polymorphisms in drug metabolizing enzymes and NSAIDs on upper gastrointestinal haemorrhage: a multicenter case-control study.
Ann Med. 2022 Dec;54(1):379-392. doi: 10.1080/07853890.2021.2016940.
4
New insight in the pathogenesis of functional gastrointestinal disorders: association between genetics and colonic transit.
Neurogastroenterol Motil. 2011 Oct;23(10):893-7. doi: 10.1111/j.1365-2982.2011.01774.x.
5
The role of pharmacogenetics in nonmalignant gastrointestinal diseases.
Nat Rev Gastroenterol Hepatol. 2012 Feb 7;9(3):173-84. doi: 10.1038/nrgastro.2012.2.
6
Role of the Gut-Brain Axis in the Shared Genetic Etiology Between Gastrointestinal Tract Diseases and Psychiatric Disorders: A Genome-Wide Pleiotropic Analysis.
JAMA Psychiatry. 2023 Apr 1;80(4):360-370. doi: 10.1001/jamapsychiatry.2022.4974.
7
The Intestinal Microenvironment and Functional Gastrointestinal Disorders.
Gastroenterology. 2016 Feb 18. doi: 10.1053/j.gastro.2016.02.028.
8
From macroautophagy to mitophagy: Unveiling the hidden role of mitophagy in gastrointestinal disorders.
World J Gastroenterol. 2024 Jun 21;30(23):2934-2946. doi: 10.3748/wjg.v30.i23.2934.
9
The dynamic influence of genetic variation on the susceptibility of sheep to gastrointestinal nematode infection.
J R Soc Interface. 2007 Oct 22;4(16):767-76. doi: 10.1098/rsif.2007.1104.
10
Impact of genetic variations in C-C chemokine receptors and ligands on infectious diseases.
Hum Immunol. 2016 Oct;77(10):961-971. doi: 10.1016/j.humimm.2016.06.010. Epub 2016 Jun 15.
本文引用的文献
1
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update.
Ann Rheum Dis. 2023 Jan;82(1):19-34. doi: 10.1136/ard-2022-223296. Epub 2022 Oct 21.
2
Human enteric viruses autonomously shape inflammatory bowel disease phenotype through divergent innate immunomodulation.
Sci Immunol. 2022 Apr 8;7(70):eabn6660. doi: 10.1126/sciimmunol.abn6660.
3
A Novel Immunobiotics Ameliorates Influenza Virus Infection in Mice.
Front Immunol. 2022 Jan 26;12:828887. doi: 10.3389/fimmu.2021.828887. eCollection 2021.
4
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021.
Gastroenterology. 2022 Feb;162(2):621-644. doi: 10.1053/j.gastro.2021.10.017. Epub 2021 Oct 19.
5
Risk for development of inflammatory bowel disease under inhibition of interleukin 17: A systematic review and meta-analysis.
PLoS One. 2020 May 27;15(5):e0233781. doi: 10.1371/journal.pone.0233781. eCollection 2020.
6
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.
Ann Rheum Dis. 2020 Jun;79(6):700-712. doi: 10.1136/annrheumdis-2020-217159.
7
Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors.
Drugs Context. 2020 Apr 21;9. doi: 10.7573/dic.2020-2-1. eCollection 2020.
8
Population Genetics in the Human Microbiome.
Trends Genet. 2020 Jan;36(1):53-67. doi: 10.1016/j.tig.2019.10.010. Epub 2019 Nov 25.
9
Update on genetic predisposition to colorectal cancer and polyposis.
Mol Aspects Med. 2019 Oct;69:10-26. doi: 10.1016/j.mam.2019.03.001. Epub 2019 Mar 18.
10
Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis.
Circulation. 2018 Nov 27;138(22):2486-2498. doi: 10.1161/CIRCULATIONAHA.118.033714.
Zotero 插件